Wednesday, April 16, 2014
FAIRFIELD-SUISUN, CALIFORNIA
99 CENTS

Gene therapy scores big wins against blood cancers

Gene Therapy Cancer

This Nov. 18, 2013 photo provided by the The Children's Hospital of Philadelphia shows Emily Whitehead, 8, 20 months after T Cell Therapy treatment in Philadelphia. In one of the biggest advances against leukemia and other blood cancers in many years, doctors are reporting unprecedented success by using gene therapy to transform patients' blood cells into soldiers that seek and destroy their cancer. (AP Photo/The Children's Hospital of Philadelphia, Ed Cunicelli)

By
From page A1 | December 08, 2013 | 1 Comment

In one of the biggest advances against leukemia and other blood cancers in many years, doctors are reporting unprecedented success by using gene therapy to transform patients’ blood cells into soldiers that seek and destroy cancer.

A few patients with one type of leukemia were given this one-time, experimental therapy several years ago and some remain cancer-free today. Now, at least six research groups have treated more than 120 patients with many types of blood and bone marrow cancers, with stunning results.

“It’s really exciting,” said Dr. Janis Abkowitz, blood diseases chief at the University of Washington in Seattle and president of the American Society of Hematology. “You can take a cell that belongs to a patient and engineer it to be an attack cell.”

In one study, all five adults and 19 of 22 children with acute lymphocytic leukemia, or ALL, had a complete remission, meaning no cancer could be found after treatment, although a few have relapsed since then.

These were gravely ill patients out of options. Some had tried multiple bone marrow transplants and up to 10 types of chemotherapy or other treatments.

Cancer was so advanced in 8-year-old Emily Whitehead of Philipsburg, Pa., that doctors said her major organs would fail within days. She was the first child given the gene therapy and shows no sign of cancer today, nearly two years later.

Results on other patients with myeloma, lymphoma and chronic lymphocytic leukemia, or CLL, will be reported at the hematology group’s conference that starts Saturday in New Orleans.

Doctors say this has the potential to become the first gene therapy approved in the United States and the first for cancer worldwide. Only one gene therapy is approved in Europe, for a rare metabolic disease.

The treatment involves filtering patients’ blood to remove millions of white blood cells called T-cells, altering them in the lab to contain a gene that targets cancer, and returning them to the patient in infusions over three days.

“What we are giving essentially is a living drug” – permanently altered cells that multiply in the body into an army to fight the cancer, said Dr. David Porter, a University of Pennsylvania scientist who led one study.

Several drug and biotech companies are developing these therapies. Penn has patented its method and licensed it to Switzerland-based Novartis AG. The company is building a research center on the Penn campus in Philadelphia and plans a clinical trial next year that could lead to federal approval of the treatment as soon as 2016.

Talking with the researchers, “there is a sense of making history … a sense of doing something very unique,” said Herv√© Hoppenot, president of Novartis Oncology, the division leading the work.

Lee Greenberger, chief scientific officer of the Leukemia and Lymphoma Society, agreed.

“From our vantage point, this looks like a major advance,” he said. “We are seeing powerful responses … and time will tell how enduring these remissions turn out to be.”

The group has given $15 million to various researchers testing this approach. Nearly 49,000 new cases of leukemia, 70,000 cases of non-Hodgkin lymphoma and 22,000 cases of myeloma are expected to be diagnosed in the United States in 2013.

Many patients are successfully treated with chemotherapy or bone marrow or stem cell transplants, but transplants are risky and donors can’t always be found. So far, gene therapy has been tried on people who were in danger of dying because other treatments failed.

The gene therapy must be made individually for each patient, and lab costs now are about $25,000, without a profit margin. That’s still less than many drugs to treat these diseases and far less than a transplant.

The treatment can cause severe flu-like symptoms and other side effects, but these have been reversible and temporary, doctors say.

Penn doctors have treated the most cases so far – 59. Of the first 14 patients with CLL, four had complete remissions, four had partial ones and the rest did not respond. However, some partial responders continue to see their cancer shrink a year after treatment.

“That’s very unique to this kind of therapy” and gives hope the treatment may still purge the cancer, said Porter. Another 18 CLL patients were treated and half have responded so far.

Penn doctors also treated 27 ALL patients. All five adults and 19 of the 22 children had complete remissions, an “extraordinarily high” success rate, said Dr. Stephan Grupp at the Children’s Hospital of Philadelphia.

Six have since relapsed, though, and doctors are pondering a second gene therapy attempt.

At the National Cancer Institute, Dr. James Kochenderfer and others have treated 11 patients with lymphoma and four with CLL, starting roughly two years ago. Six had complete remissions, six had partial ones, one has stable disease and it’s too soon to tell for the rest.

Ten other patients were given gene therapy to try to kill leukemia or lymphoma remaining after bone marrow transplants. These patients got infusions of gene-treated blood cells from their transplant donors instead of using their own blood cells. One had a complete remission and three others had significant reduction of their disease.

“They’ve had every treatment known to man. To get any responses is really encouraging,” Kochenderfer said. The cancer institute is working with a Los Angeles biotech firm, Kite Pharma Inc., on its gene therapy approach.

Researchers at Memorial Sloan-Kettering Cancer Center will report on 13 patients with ALL; the University of Texas MD Anderson Cancer Center will report about two-dozen patients with ALL or lymphoma, and Baylor University will give results on 10 patients with lymphoma or myeloma.

Patients are encouraged that relatively few have relapsed.

“We’re still nervous every day because they can’t tell us what’s going to happen tomorrow,” said Tom Whitehead, 8-year-old Emily’s father.

Doug Olson, 67, a scientist for a medical device maker, shows no sign of cancer since gene therapy in September 2010 for CLL he had had since 1996.

“Within one month he was in complete remission. That was just completely unexpected,” said Porter, his doctor at Penn.

Olson ran his first half-marathon in January and no longer worries about how long his remission will last.

“I decided I’m cured. I’m not going to let that hang over my head anymore,” he said.

___

Online:

Emily Whitehead’s story: http://bit.ly/VxB0dL

The Associated Press

The Associated Press

LEAVE A COMMENT

Discussion | 1 comment

The Daily Republic does not necessarily condone the comments here, nor does it review every post. Read our full policy

.

Solano News

 
 
 
Suisun police ID shooting victim

By Ian Thompson | From Page: A3, 6 Comments

 
Solano Jews gather for start of Passover

By Amy Maginnis-Honey | From Page: A3 | Gallery

 
 
County discusses consolidated dispatch

By Barry Eberling | From Page: A4

 
Miner Slough Bridge to see repairs

By Barry Eberling | From Page: A4

 
‘Heaven is for Real’ opens Wednesday

By Amy Maginnis-Honey | From Page: B5

 
Fiesta Days pageant organizers seek contestants

By Amy Maginnis-Honey | From Page: A5

 
Easter hunt set for Mare Island

By Barry Eberling | From Page: A5

 
Crews make quick work of vehicle fire

By Glen Faison | From Page: A6, 6 Comments | Gallery

 
Paper Clover Campaign supports Solano County 4-H

By Amy Maginnis-Honey | From Page: A6

Coakley joins Solano fair board

By Barry Eberling | From Page: A6

 
Hundreds flock to Krispy Kreme as it opens doors

By Susan Winlow | From Page: B9, 1 Comment | Gallery

 
County to honor Solano educators

By Barry Eberling | From Page: A14, 1 Comment

.

US / World

Officials: Huge San Francisco blaze was accidental

By The Associated Press | From Page: A10

 
‘Shrimp Boy’ pleads not guilty in corruption case

By The Associated Press | From Page: A10, 1 Comment

Solemn tributes mark Boston Marathon bombing

By The Associated Press | From Page: A10, 1 Comment | Gallery

 
Immigration activists urge Obama to act boldly

By The Associated Press | From Page: A11, 1 Comment

Supremacist faces murder charges in Kansas deaths

By The Associated Press | From Page: A14

 
Ukraine: Military secures airport from attack

By The Associated Press | From Page: A14

Democrats have outside money advantage – for now

By The Associated Press | From Page: A14, 3 Comments

 
First women move into Army platoon artillery jobs

By The Associated Press | From Page: A14

Final deadline arrives for health exchange sign-up

By The Associated Press | From Page: A14, 1 Comment

 
New LA newspaper embraces print in digital world

By The Associated Press | From Page: A14

Congress is giving states the transportation blues

By The Associated Press | From Page: A14, 2 Comments

 
Police: Suspects in killings wore GPS devices

By The Associated Press | From Page: A14, 1 Comment

DNA alternative to Pap smear sparks medical debate

By The Associated Press | From Page: A14

 
Robot sub returns to water after 1st try cut short

By The Associated Press | From Page: A14

Hamas praises deadly West Bank shooting

By The Associated Press | From Page: A15

 
2 dead after ferry sinks off SKorean coast

By The Associated Press | From Page: A15

.

Opinion

 
Oh, for the days of Dr. Welby

By Dan K. Thomasson | From Page: A13, 13 Comments

Poor Judgement in Flight 370 column

By Letter to the Editor | From Page: A13, 1 Comment

 
Senseless babble that hurts

By Letter to the Editor | From Page: A13, 2 Comments

 
Expand Red Top Road

By Letter to the Editor | From Page: A13, 2 Comments

Editorial cartoons for April 16, 2014

By Daily Republic Syndicated Content | From Page: A13

 
.

Living

Community Calendar: April 16, 2014

By Susan Hiland | From Page: A2

 
What love gives you

By Barton Goldsmith | From Page: A2

Today in History for April 16, 2014

By The Associated Press | From Page: A2

 
A matzo ball soup fit for a weeknight dinner

By The Associated Press | From Page: B6

Saving carrots from their usual sugary Easter fate

By Sara Moulton | From Page: B6

 
Sweet pairings for grown-up Easter treats

By The Associated Press | From Page: B6

My husband still pays his 45-year-old unemployed son’s bills

By Kathy Mitchell and Marcy Sugar | From Page: B7

 
Horoscopes for April 16, 2014

By Holiday Mathis | From Page: B7

.

Entertainment

Boston Globe wins Pulitzer for bombing coverage

By The Associated Press | From Page: B5

 
Lindsay Lohan’s mom pleads guilty to DWI in NY

By The Associated Press | From Page: B5

Strahan’s ‘GMA’ side job confirmed with his visit

By The Associated Press | From Page: B5

 
TVGrid

By Daily Republic Syndicated Content | From Page: A11

.

Sports

Cal hires Tennessee’s Cuonzo Martin as coach

By The Associated Press | From Page: B1

 
Warriors trying to move on without Andrew Bogut

By The Associated Press | From Page: B1

Sharks’ Torres uncertain for playoff opener

By The Associated Press | From Page: B1

 
Indians shut out Mustangs

By Marcus Lomtong | From Page: B1, 1 Comment | Gallery

Ex-Minnesota State, Mankato coach returning to job

By The Associated Press | From Page: B2

 
Panthers jump Sabres to win NHL draft lottery

By The Associated Press | From Page: B2

More former players sue NHL regarding concussions

By The Associated Press | From Page: B2

 
49ers sign WR Brandon Lloyd to 1-year deal

By The Associated Press | From Page: B2

MLB marks 67th anniversary of Jackie Robinson’s debut

By The Associated Press | From Page: B2

 
.

Business

Twitter buys data analytics partner Gnip

By The Associated Press | From Page: A14

 
Yellen signals more aggressive stance toward banks

By The Associated Press | From Page: A14

.

Obituaries

Carolyn McClelland

By Nancy Green | From Page: A4

 
Evonne Medina

By Nancy Green | From Page: A4, 1 Comment

.

Comics

Blondie

By Daily Republic Syndicated Content | From Page: B6

 
Garfield

By Daily Republic Syndicated Content | From Page: B6

Peanuts

By Daily Republic Syndicated Content | From Page: B6

 
Pickles

By Daily Republic Syndicated Content | From Page: B6

Wizard of Id

By Daily Republic Syndicated Content | From Page: B6

 
For Better or Worse

By Daily Republic Syndicated Content | From Page: B6

Beetle Bailey

By Daily Republic Syndicated Content | From Page: B6

 
Zits

By Daily Republic Syndicated Content | From Page: B6

Rose is Rose

By Daily Republic Syndicated Content | From Page: B6

 
Sally Forth

By Daily Republic Syndicated Content | From Page: B6

B.C.

By Daily Republic Syndicated Content | From Page: B6

 
Baldo

By Daily Republic Syndicated Content | From Page: B6

Baby Blues

By Daily Republic Syndicated Content | From Page: B6

 
Dilbert

By Daily Republic Syndicated Content | From Page: B6

Frank and Ernest

By Daily Republic Syndicated Content | From Page: B6

 
Get Fuzzy

By Daily Republic Syndicated Content | From Page: B6

Sudoku

By Daily Republic Syndicated Content | From Page: B7

 
Bridge

By Daily Republic Syndicated Content | From Page: B7

Cryptoquote

By Daily Republic Syndicated Content | From Page: B7

 
Word Sleuth

By Daily Republic Syndicated Content | From Page: B7

Crossword

By Daily Republic Syndicated Content | From Page: B7